In honor of Leukemia and Lymphoma Awareness Month in September, Dr. Richard I. Fisher, President and CEO of Fox Chase Cancer Center, spoke about his seminal paper on the CHOP regimen for the treatment of advanced non-Hodgkin’s lymphoma. It was publish...
Read More
Updated: 2019Prostate cancer is the second most common cancer among men, with some 200,000 cases diagnosed in the U.S. each year.“Considering how often prostate cancer occurs in men, every man should familiarize himself with its signs and risk factors,” sai...
Read More
Alexander Kutikov, MD, FACS, has been appointed the new Chief of the Division of Urologic Oncology in the Department of Surgical Oncology at Fox Chase Cancer Center. Kutikov joined the Department of Surgical Oncology at Fox Chase after completing a Society ...
Read More
Treatment methods are constantly emerging in the field of prostate cancer. Focal therapy has become an option in treating some men that have been diagnosed with prostate cancer.Men with small, localized prostate tumors may be eligible for this treatment whi...
Read More
For some men who need a prostate biopsy to test for prostate cancer, Fox Chase Cancer Center offers an alternative approach that is safer, with significantly lower risks of infection, and potentially higher rate of tumor detection.Most prostate biopsies are...
Read More
Robert Uzzo, MD, FACS, Chair of the Department of Surgical Oncology at Fox Chase Cancer Center, is the recipient of the President’s Distinguished Service Award from the Society of Urologic Oncology (SUO). The award was presented at the American Urology Asso...
Read More
